BACKGROUND: There are few data on the prevalence of cardiometabolic risk factors in population-based samples of overweight and obese youth. OBJECTIVES: To compare the prevalence of individual and multiple cardiometabolic risk factors across body mass index (BMI) categories in a population-based sample of youth. METHODS: In 1999, a school-based survey of a provincially representative sample of youth nine, 13 and 16 years of age was conducted in Quebec (1778 boys, 1835 girls). Overweight was defined as BMI in the 85th percentile or higher and lower than the 95th percentile of the Centers for Disease Control and Prevention 2000 growth charts, and obesity was defined as BMI in the 95th percentile or higher. Levels of total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, high-density lipoprotein cholesterol, triglycerides, insulin, glucose, C-reactive protein and systolic blood pressure were categorized as desirable, borderline or unfavourable. RESULTS: The proportions of overweight and obese participants were 14% and 10% in boys, and 14% and 7% in girls, respectively. With the exception of total cholesterol and low-density lipoprotein cholesterol in girls, and glucose in both sexes, the prevalence of all investigated risk factors (borderline or unfavourable) was significantly higher among overweight and obese participants. Almost one-third of obese participants had unfavourable levels of at least two of seven risk factors (apolipoprotein B, high-density lipoprotein cholesterol, triglycerides, insulin, glucose, C-reactive protein and systolic blood pressure) compared with 3% of normal weight participants (adjusted OR 15 and 18 in boys and girls, respectively). Thirty-four per cent of obese youth did not have unfavourable levels of any risk factor. CONCLUSION: There is marked heterogeneity in the association between excess weight and cardiometabolic risk factors. Nonetheless, the present study highlights a high prevalence of multiple risk factors in a population-based sample of overweight and obese youth.
BACKGROUND: There are few data on the prevalence of cardiometabolic risk factors in population-based samples of overweight and obese youth. OBJECTIVES: To compare the prevalence of individual and multiple cardiometabolic risk factors across body mass index (BMI) categories in a population-based sample of youth. METHODS: In 1999, a school-based survey of a provincially representative sample of youth nine, 13 and 16 years of age was conducted in Quebec (1778 boys, 1835 girls). Overweight was defined as BMI in the 85th percentile or higher and lower than the 95th percentile of the Centers for Disease Control and Prevention 2000 growth charts, and obesity was defined as BMI in the 95th percentile or higher. Levels of total cholesterol, low-density lipoprotein cholesterol, apolipoprotein B, high-density lipoprotein cholesterol, triglycerides, insulin, glucose, C-reactive protein and systolic blood pressure were categorized as desirable, borderline or unfavourable. RESULTS: The proportions of overweight and obeseparticipants were 14% and 10% in boys, and 14% and 7% in girls, respectively. With the exception of total cholesterol and low-density lipoprotein cholesterol in girls, and glucose in both sexes, the prevalence of all investigated risk factors (borderline or unfavourable) was significantly higher among overweight and obeseparticipants. Almost one-third of obeseparticipants had unfavourable levels of at least two of seven risk factors (apolipoprotein B, high-density lipoprotein cholesterol, triglycerides, insulin, glucose, C-reactive protein and systolic blood pressure) compared with 3% of normal weight participants (adjusted OR 15 and 18 in boys and girls, respectively). Thirty-four per cent of obese youth did not have unfavourable levels of any risk factor. CONCLUSION: There is marked heterogeneity in the association between excess weight and cardiometabolic risk factors. Nonetheless, the present study highlights a high prevalence of multiple risk factors in a population-based sample of overweight and obese youth.
Authors: Pierre Allard; Edgard E Delvin; Gilles Paradis; James A Hanley; Jennifer O'Loughlin; Claudette Lavallée; Emile Levy; Marie Lambert Journal: Clin Chem Date: 2003-04 Impact factor: 8.327
Authors: Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor Journal: Circulation Date: 2003-01-28 Impact factor: 29.690
Authors: Gilles Paradis; Marie Lambert; Jennifer O'Loughlin; Claudette Lavallée; Jacinthe Aubin; Paul Berthiaume; Marielle Ledoux; Edgard E Delvin; Emile Lévy; James A Hanley Journal: Can J Cardiol Date: 2003-04 Impact factor: 5.223
Authors: J J Reilly; E Methven; Z C McDowell; B Hacking; D Alexander; L Stewart; C J H Kelnar Journal: Arch Dis Child Date: 2003-09 Impact factor: 3.791
Authors: Olli T Raitakari; Markus Juonala; Mika Kähönen; Leena Taittonen; Tomi Laitinen; Noora Mäki-Torkko; Mikko J Järvisalo; Matti Uhari; Eero Jokinen; Tapani Rönnemaa; Hans K Akerblom; Jorma S A Viikari Journal: JAMA Date: 2003-11-05 Impact factor: 56.272
Authors: David S Freedman; Janet E Fulton; William H Dietz; Liping Pan; Allison J Nihiser; Sathanur R Srinivasan; Gerald S Berenson Journal: Am J Clin Nutr Date: 2010-10-27 Impact factor: 7.045
Authors: Mélanie Henderson; Katherine Gray-Donald; Marie-Eve Mathieu; Tracie A Barnett; James A Hanley; Jennifer O'Loughlin; Angelo Tremblay; Marie Lambert Journal: Diabetes Care Date: 2012-04-09 Impact factor: 19.112
Authors: Teatske M Altenburg; Geesje H Hofsteenge; Peter J M Weijs; Henriette A Delemarre-van de Waal; Mai J M Chinapaw Journal: PLoS One Date: 2012-12-28 Impact factor: 3.240